Marine Industries Global Market Analysis - Marine Institute

MARINE INDUSTRIES GLOBAL MARKET ANALYSIS
21
2009, representing a slight decline of 0.6% annually from 2005 following a peak of
€74 billion in 2006.This is due to a forecast slight decline in shipbuilding.
There is growing technology content and hundreds of high-tech sub-sectors, many of
which offer opportunities.
MARINE IT
Page 113 (€3.4bn in 2004, €3.4bn in 2009)
In 2004 the world value of Marine IT was €3.6 billion. Europe’s share was
€1.4 billion, amounting to nearly 40% of the world market.
There are more than 500 suppliers of ‘marine computing’ worldwide (mainly SMEs,
plus many leisure sector players). IT hardware & software applies to, and is embedded
in all aspects of marine activity so it is difficult to value.The major sectors are ship
operations (e.g. integrated bridge), equipment support (e.g. engine management),
marine operations (e.g. cargo handling) and design.
1999–03 2004 2005–09
Irish Market €M 43 18 78
UK Market €M 648 217 917
Europe Market €M 3,794 1,382 5,872
World Market €M 9,780 3,570 16,012
Marine IT has grown substantially from €1.3 billion in 1999.There is an overall longterm
increase in IT content in the marine sector and it could hold significant
potential for Ireland. Globally, the sector is set for its long-term steady growth to
continue; however, after a peak in 2004, annual growth is forecast at –0.9%, although
total period growth 2005–2009 is 7%.
MARINE BIOTECHNOLOGY
Page 113 (€2.2bn in 2004, €2.6bn in 2009)
In 2004 the global value of marine biotechnology was €2.2 billion. As the sector is in
the early stages of its development, there is at present insufficient information on
which to base country or regional segmentation of these estimates.
80% of living organisms are found only in aquatic ecosystems, yet little is known
about their biochemical characteristics.This is a new sector with considerable interest
being shown by the US, Japan, the UK and others.There have been some initial
successes (the US Sea Grant programme, with small investments, developed five drugs
“with market potential of $2bn p.a.”) and considerable long-term potential beyond
the timeframe of this report.
1999–03 2004 2005–09
Irish market €M – – –
UK market €M – – –
Europe market €M – – –
World market €M 11,350 2,190 11,848